The State Of CRISPR Clinical Trials And Their Future Potentials

CRISPR, short for “Clustered Regularly Interspaced Short Palindromic Repeats” – and more specifically CRISPR–Cas9 – relates to a gene-editing method that gained popularity in the past decade; and not for trivial reasons. Being the most efficient and accurate method to edit a cell’s genome, CRISPR holds potentials that range from treating conditions such as HIV to finding new drug targets. While such potentials are real and are being actively investigated, you might be curious about more practical examples of CRISPR applications. By taking the US Clinical Trials registry as an example, we consider listed clinical trials that involve CRISPR technology as of late November 2023. Such an undertaking can provide a better appreciation of the state of CRISPR potential, as well as practical use cases that we can expect in the coming years. Clinical trials involving CRISPR  For this analysis, we looked at the CRISPR entries on ClinicalTrials.gov, which is an online database of clinical research studies and shares information about their results. This database is maintained by the United States National Library of Medicine at the National Institutes of Health and holds registrations from over 444,000 trials from 221 countries. At the time of writing, 51 CRISPR/Cas9-related studies were identified on ClinicalTrials.gov and they could roughly be categorised as completed, ongoing, or terminated based on their statuses. 1. Completed CRISPR clinical tr...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: TMF CRISPR therapy clinical trials gene editing Source Type: blogs